The neonatal respiratory care devices market share in 2026 is gaining importance as healthcare providers increasingly focus on improving respiratory support for newborns requiring intensive care. These devices play an important role in neonatal intensive care units (NICUs), particularly for premature babies and newborns experiencing respiratory distress. According to Fortune Business Insights, the global neonatal intensive care respiratory devices market size was valued at USD 2.05 billion in 2025 and is projected to grow from USD 2.17 billion in 2026 to USD 3.08 billion by 2034, exhibiting a CAGR of 4.47% during 2026-2034.
Neonatal respiratory care devices include equipment and related products used to support breathing and oxygen delivery among newborns. The market covers devices such as mechanical ventilators, bubble continuous positive airway pressure (CPAP) systems, extracorporeal membrane oxygenation (ECMO), and other respiratory equipment. It also includes accessories and consumables such as nasal prong cannulas, masks, resuscitators, breathing circuits, and other products used in neonatal respiratory care.
According to Fortune Business Insights, approximately 15 million babies are born prematurely worldwide each year, representing around 11% of births. Premature newborns frequently require intensive care and respiratory support because their lungs may not be fully developed. Respiratory distress syndrome (RDS) is a major respiratory condition among neonates and is associated with premature delivery. The increasing prevalence of respiratory distress and the resulting need for intensive respiratory management are contributing to demand for neonatal respiratory care devices.
The increasing number of NICU admissions is also supporting market development. Respiratory devices such as nasal cannulas, resuscitators, ventilators, and CPAP systems are used to provide respiratory support to newborns. The growing requirement for effective respiratory management is encouraging manufacturers to develop products designed specifically for neonatal applications.
Technological advancement is another important factor supporting the neonatal respiratory care devices market. Companies are focusing on developing advanced products that can provide effective respiratory support and improve neonatal care. Increasing demand for technologically advanced ventilators, CPAP systems, and accessories has encouraged manufacturers to strengthen research and development activities.
Strategic agreements, collaborations, acquisitions, and product launches are also influencing the competitive environment. For example, SLE launched the OxyGenie Auto O2 controller for the SLE 6000 in November 2018. The product was designed to control oxygen delivery and maintain neonatal patients’ SpO2 levels within a specified range. Such product developments demonstrate the industry's focus on sophisticated neonatal respiratory care solutions.
The major market driver is the increasing incidence of respiratory distress among newborns. Respiratory distress syndrome is a common condition in premature infants and is a major reason for NICU admissions. The need for continuous oxygen and respiratory support contributes to demand for nasal cannulas, resuscitators, ventilators, CPAP devices, and other respiratory products.
Another growth factor is the increasing focus of key companies on developing advanced neonatal respiratory care devices. Product innovation and technological improvements are supporting demand for ventilators, CPAP systems, and related accessories across developed and emerging markets.
However, limited adoption of advanced respiratory care devices in low- and middle-income countries remains a restraint. Slower healthcare infrastructure development, limited funding, and insufficient awareness regarding NICU care guidelines can affect the adoption of sophisticated respiratory equipment. These factors may restrict product demand in certain markets.
The global market is consolidated, with a limited number of companies accounting for a significant share. Fisher & Paykel Healthcare Corporation holds a prominent position due to its range of neonatal respiratory care devices and consumables. Drägerwerk AG & Co. KGaA and GE Healthcare have also made significant investments in research and development.
Companies are focusing on continuous product improvements, strategic acquisitions, technological developments, and collaborations to strengthen their market positions. Key industry developments include the launch of portable neonatal CPAP systems and regulatory approvals for neonatal positive airway pressure systems.
Airon Corporation
Drägerwerk AG & Co. KGaA
Fisher & Paykel Healthcare Limited